Literature DB >> 29520049

Prophylactic laser in age-related macular degeneration: the past, the present and the future.

Quan Findlay1, Andrew I Jobling1, Kirstan A Vessey1, Ursula Greferath1, Joanna A Phipps1, Robyn H Guymer2, Erica L Fletcher1.   

Abstract

The presence of drusen in the posterior eye is a hallmark feature of the early stages of age-related macular degeneration and their size is an indicator of risk of progression to vision-threatening forms of the disease. Since the initial observations that laser treatment can resolve drusen, there has been great interest in whether laser treatment can be used to reduce the progression of age-related macular degeneration. In this article, we review the development of lasers for the treatment of those with age-related macular degeneration. We provide an overview of the clinical trial results that demonstrated drusen resolution but that had mixed effects on progression of disease. In addition, we provide a summary of the recent developments in pulsed lasers that are designed to reduce the energy applied to the posterior eye to provide the therapeutic effects of conventional continuous wave lasers while reducing the secondary tissue effects.

Mesh:

Year:  2018        PMID: 29520049      PMCID: PMC5944648          DOI: 10.1038/s41433-018-0035-1

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  53 in total

1.  Nanosecond laser therapy reverses pathologic and molecular changes in age-related macular degeneration without retinal damage.

Authors:  A I Jobling; R H Guymer; K A Vessey; U Greferath; S A Mills; K H Brassington; C D Luu; K Z Aung; L Trogrlic; M Plunkett; E L Fletcher
Journal:  FASEB J       Date:  2014-11-12       Impact factor: 5.191

2.  Laser-mediated activation of human retinal pigment epithelial cells and concomitant release of matrix metalloproteinases.

Authors:  Jin Jun Zhang; Yue Sun; Ali A Hussain; John Marshall
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-17       Impact factor: 4.799

3.  Ageing changes in Bruch's membrane and their functional implications.

Authors:  C F Grindle; J Marshall
Journal:  Trans Ophthalmol Soc U K       Date:  1978-04

4.  Nanosecond pulse lasers for retinal applications.

Authors:  John P M Wood; Malcolm Plunkett; Victor Previn; Glyn Chidlow; Robert J Casson
Journal:  Lasers Surg Med       Date:  2011-08       Impact factor: 4.025

5.  Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study.

Authors:  J Duvall; M O Tso
Journal:  Arch Ophthalmol       Date:  1985-05

Review 6.  Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex.

Authors:  Imran Bhutto; Gerard Lutty
Journal:  Mol Aspects Med       Date:  2012-04-21

7.  Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.

Authors: 
Journal:  Ophthalmology       Date:  2006-11       Impact factor: 12.079

8.  Foveal drusen resorption one year after perifoveal laser photocoagulation.

Authors:  J Sigelman
Journal:  Ophthalmology       Date:  1991-09       Impact factor: 12.079

Review 9.  Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.

Authors:  Maurizio B Parodi; Gianni Virgili; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Authors: 
Journal:  JAMA       Date:  2013-05-15       Impact factor: 56.272

View more
  3 in total

Review 1.  Medication Trends for Age-Related Macular Degeneration.

Authors:  Yeon-Kyoung Cho; Dae-Hun Park; In-Chul Jeon
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

Review 2.  Stem/progenitor cell-based transplantation for retinal degeneration: a review of clinical trials.

Authors:  Yiqi Wang; Zhimin Tang; Ping Gu
Journal:  Cell Death Dis       Date:  2020-09-23       Impact factor: 8.469

Review 3.  Therapy of Pseudoxanthoma Elasticum: Current Knowledge and Future Perspectives.

Authors:  Max Jonathan Stumpf; Nadjib Schahab; Georg Nickenig; Dirk Skowasch; Christian Alexander Schaefer
Journal:  Biomedicines       Date:  2021-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.